They reported that annexin A4 might facilitate HCC cell migration and invasion via regulating epithelial-mesenchymal transition and they concluded that patients with high levels of ANXA4 had higher recurrence rate and shorter overall survival than those with low expression. The gene discussed is ANXA4; the disease is hepatocellular carcinoma.